These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36581225)

  • 1. Mefloquine loaded niosomes as a promising approach for the treatment of acute and chronic toxoplasmosis.
    El Sharazly BM; Aboul Asaad IA; Yassen NA; El Maghraby GM; Carter WG; Mohamed DA; Amer BS; Ismail HIH
    Acta Trop; 2023 Mar; 239():106810. PubMed ID: 36581225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis.
    El-Kowrany SI; El Ghaffar AEA; Shoheib ZS; Mady RF; Gamea GAM
    Acta Trop; 2019 Jul; 195():145-154. PubMed ID: 30986380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urtica dioica Extract Leads to Cyst Reduction, Enhanced Cell-Mediated Immune Response, and Antioxidant Activity in Experimental Toxoplasmosis.
    Peyvandi A; Gorgani-Firouzjaee T; Najafzadehvarzi H; Jafarzadeh J
    Acta Parasitol; 2023 Dec; 68(4):880-890. PubMed ID: 37924457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice.
    Abdelhamid Elgendy WM; Haggag YA; El-Nouby KA; El-Kowrany SI; El Marhoumy SM
    Exp Parasitol; 2023 Mar; 246():108460. PubMed ID: 36642299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The High Potency of Green Synthesized Copper Nanoparticles to Prevent the Toxoplasma gondii Infection in Mice.
    Albalawi AE; Alanazi AD; Alyousif MS; Sepahvand A; Ebrahimi K; Niazi M; Mahmoudvand H
    Acta Parasitol; 2021 Dec; 66(4):1472-1479. PubMed ID: 34050875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Thymus vulgaris ethanolic extract on chronic toxoplasmosis in a mouse model.
    Eraky MA; El-Fakahany AF; El-Sayed NM; Abou-Ouf EA; Yaseen DI
    Parasitol Res; 2016 Jul; 115(7):2863-71. PubMed ID: 27098159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfadiazine Plus Pyrimethamine Therapy Reversed Multiple Behavioral and Neurocognitive Changes in Long-Term Chronic Toxoplasmosis by Reducing Brain Cyst Load and Inflammation-Related Alterations.
    Castaño BL; Silva AA; Hernandez-Velasco LL; Pinheiro APDS; Gibaldi D; Mineo JR; Silva NM; Lannes-Vieira J
    Front Immunol; 2022; 13():822567. PubMed ID: 35572567
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S; Pudney M; Derouin F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HIV aspartyl protease inhibitors on experimental infection with a cystogenic Me49 strain of
    Abou-El-Naga IF; Gomaa MM; ElAchy SN
    Pathog Glob Health; 2022 Mar; 116(2):107-118. PubMed ID: 34420500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
    Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine.
    Schoondermark-van de Ven E; Galama J; Vree T; Camps W; Baars I; Eskes T; Meuwissen J; Melchers W
    Antimicrob Agents Chemother; 1995 Jan; 39(1):137-44. PubMed ID: 7695295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-parasitic activity of a chimeric peptide Cecropin A (2-8)-Melittin (6-9) (CM11) against tachyzoites of Toxoplasma gondii and the BALB/c mouse model of acute toxoplasmosis.
    Abbasali Z; Pirestani M; Dalimi A; Badri M; Fasihi-Ramandi M
    Mol Biochem Parasitol; 2023 Sep; 255():111578. PubMed ID: 37348706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
    Jost C; Reiter-Owona I; Liesenfeld O
    Parasitol Res; 2007 Nov; 101(6):1603-9. PubMed ID: 17846793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
    Araujo FG; Prokocimer P; Lin T; Remington JS
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2454-7. PubMed ID: 1489188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
    Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.
    Harper JS; London WT; Sever JL
    Am J Trop Med Hyg; 1985 Jan; 34(1):50-7. PubMed ID: 3970309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model.
    Abdel-Wahab AA; Shafey DA; Selim SM; Sharaf SA; Mohsen KK; Allam DM; Elkhadry SW; Gouda MA
    Parasitol Res; 2024 Jul; 123(7):286. PubMed ID: 39046555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.